Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)

Market Cap	12.48B -1.4%
Revenue (ttm)	5.22B +0.8%
Net Income	651.95M +5.2%
EPS	0.73 +4.5%
Shares Out	881.71M
PE Ratio	19.39
Forward PE	12.32
Dividend	0.30 (2.14%)
Ex-Dividend Date	Sep 8, 2025

Volume	23,547,739
Average Volume	18,154,582
Open	14.05
Previous Close	14.02
Day's Range	14.05 - 14.37
52-Week Range	13.66 - 22.25
Beta	0.30
RSI	26.43
Earnings Date	Apr 24, 2026

About SHA:603456

Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization (CDMO) company in China and internationally. The company offers small molecule, drug product, and peptide CDMO services. It also involved in business related to supporting the development of new drugs and pharmaceuticals. It serves global pharmaceutical companies, biotechnology companies, and scientific research institutions. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1973
• Employees: 5,001
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603456

Financial Performance

In 2025, SHA:603456's revenue was 5.51 billion, an increase of 6.74% compared to the previous year's 5.16 billion. Earnings were 730.07 million, an increase of 20.46%.